Cobimetinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Cobimetinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso Impurity 2 CAS NO:NA chemically represented as (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(1-nitrosopiperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso Impurity 2 . We supply Cobimetinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines."
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142980 |
| CAS No | NA |
| Mol.F. | C25H29N3O5 |
| Mol.Wt. | 451.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142981 |
| CAS No | NA |
| Mol.F. | C15H20N2O4 |
| Mol.Wt. | 292.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142982 |
| CAS No | NA |
| Mol.F. | C25H29N3O5 |
| Mol.Wt. | 451.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142983 |
| CAS No | NA |
| Mol.F. | C21H21FN4O5 |
| Mol.Wt. | 428.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142984 |
| CAS No | NA |
| Mol.F. | C15H21FN4O4 |
| Mol.Wt. | 340.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142985 |
| CAS No | NA |
| Mol.F. | C13H17ClFN3O3 |
| Mol.Wt. | 317.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142986 |
| CAS No | NA |
| Mol.F. | C18H18FN3O4 |
| Mol.Wt. | 359.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142987 |
| CAS No | NA |
| Mol.F. | C16H20N4O5 |
| Mol.Wt. | 348.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142988 |
| CAS No | NA |
| Mol.F. | C13H16FN3O3 |
| Mol.Wt. | 281.29 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142989 |
| CAS No | NA |
| Mol.F. | C12H14FN3O3 |
| Mol.Wt. | 267.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142990 |
| CAS No | NA |
| Mol.F. | C16H19FN4O6 |
| Mol.Wt. | 382.35g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142991 |
| CAS No | NA |
| Mol.F. | C15H21FN4O4 |
| Mol.Wt. | 340.36g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142992 |
| CAS No | NA |
| Mol.F. | C16H19FN4O4S |
| Mol.Wt. | 382.41g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142993 |
| CAS No | NA |
| Mol.F. | C14H17FN4O5 |
| Mol.Wt. | 340.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142994 |
| CAS No | NA |
| Mol.F. | C17H21FN4O5 |
| Mol.Wt. | 380.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142995 |
| CAS No | NA |
| Mol.F. | C172H264N44O52 |
| Mol.Wt. | 3780.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |